Conclusion: Ginkgo biloba extracts have shown the greatest cognitive and functional benefits, though their clinical significance remains uncertain, and certainty of evidence is overall low. Future trials should focus on a single VCI subtype, prioritize interventions with a strong mechanistic rationale, standardize diagnostic criteria, ensure adequate power for chosen outcomes, test against placebo, and implement FAIR data sharing to accelerate therapeutic discovery.
PubMed 41198594 ↗Cerebrolysin
The short answer. More people than not who report on Cerebrolysin say it helped (73% of 59). It is most often used for memory: 97% of 31 reports say that improved. It is well studied — 30 meta-analyses on PubMed. It is not an approved supplement and carries real risks.
From 228 mentions in total — the rest didn't say how it went and aren't counted.
What Cerebrolysin does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 30 meta-analyses on PubMed ↗ · 60 randomized trials ↗
Conclusion: The findings of this Cochrane Review do not demonstrate clinical benefits of cerebrolysin for treating acute ischaemic stroke. We found moderate-quality evidence suggesting that serious adverse events may be more common with cerebrolysin use in acute ischaemic stroke.
PubMed 27918088 ↗Conclusion: The findings of this Cochrane Review do not demonstrate clinical benefits of cerebrolysin for treating acute ischaemic stroke. We found moderate-quality evidence of an increase in non-fatal SAEs with cerebrolysin use but not in total SAEs.
PubMed 28430363 ↗Conclusion: Cerebrolysin may have positive effects on cognitive function and global function in elderly patients with vascular dementia of mild to moderate severity, but there is still insufficient evidence to recommend Cerebrolysin as a routine treatment for vascular dementia due to the limited number of included trials, wide variety of treatment durations and short-term follow-up in most of the trials.
PubMed 23440834 ↗43 human trials on ClinicalTrials.gov test Cerebrolysin — 19 completed, 4 recruiting now. See all on ClinicalTrials.gov ↗
- Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU · Traumatic Brain Injury · 2025
- Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness · Acute Ischemic Stroke · 2024
- Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants · Post-covid-19 Persistent Smell and Taste Disorders · 2024
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Cerebrolysin is by far the best nootropic I have ever used...my memory, recall ability, sensitivity to music, observance over my emotions, thinking faculties have all improved to a noticeable amount.”
“After ~15 mins of administration of any of these, I'm starting to feel tingling all over the body, weakness, noticeable drop in mood and cognition.”
“Cerebrolysin also helped me recover from over a decade of extreme stimulant abuse. No hyperbole, I went from barely functioning as a human to achieving the highest license and certification in my field.”
“i used cerebrolysin to quit kratom. it worked i had no withdrawals it’s not an opiate either it causes neuroregeneration.”
Cerebrolysin compared
Other options for memory
Sources
- User reports: 228 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate